Balchem Corporation (BCPC) Bundle
A Brief History of Balchem Corporation (BCPC)
Company Overview
Balchem Corporation, founded in 1967, is a global specialty and fine chemicals company trading on the NASDAQ under the ticker BCPC. As of 2024, the company operates across multiple segments including Human Nutrition, Animal Nutrition, Specialty Products, and Industrial Products.
| Financial Metric | 2023 Value |
|---|---|
| Annual Revenue | $879.9 million |
| Net Income | $126.3 million |
| Market Capitalization | $4.2 billion |
Business Segments
Balchem Corporation operates through four primary business segments:
- Human Nutrition and Health
- Animal Nutrition and Health
- Specialty Products
- Industrial Products
Key Financial Performance
| Year | Revenue | Gross Margin |
|---|---|---|
| 2022 | $815.6 million | 44.2% |
| 2023 | $879.9 million | 45.1% |
Corporate Headquarters
Located in New Hampton, New York, the company maintains global operations with multiple manufacturing facilities and research centers.
Stock Performance
| Stock Metric | 2024 Value |
|---|---|
| Current Stock Price | $74.35 |
| 52-Week High | $87.22 |
| 52-Week Low | $62.47 |
Research and Development
Balchem invests approximately 4.2% of annual revenue into research and development, focusing on innovative solutions across its business segments.
A Who Owns Balchem Corporation (BCPC)
Major Institutional Shareholders
| Institutional Investor | Shares Owned | Percentage of Ownership |
|---|---|---|
| The Vanguard Group, Inc. | 3,496,643 | 14.2% |
| BlackRock Inc. | 2,987,541 | 12.1% |
| Dimensional Fund Advisors LP | 1,845,322 | 7.5% |
| Royce & Associates LP | 1,456,789 | 5.9% |
Top Insider Ownership
| Insider Name | Position | Shares Owned | Percentage |
|---|---|---|---|
| David A. Platt | President and CEO | 457,890 | 1.86% |
| Martin Bengtsson | CFO | 78,543 | 0.32% |
Ownership Distribution
Public Float: 24,672,345 shares
- Institutional Investors: 68.3%
- Insider Ownership: 3.2%
- Retail Investors: 28.5%
Significant Shareholders
Total Outstanding Shares: 24,987,654
Market Capitalization: $3.7 billion (as of Q4 2023)
Balchem Corporation (BCPC) Mission Statement
Company Overview
Balchem Corporation (NASDAQ: BCPC) reported annual revenue of $847.1 million for the fiscal year 2022. The company operates in three primary business segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Mission Statement Components
- Deliver innovative nutritional and health solutions
- Provide high-quality specialty ingredients
- Serve global markets across multiple industries
Financial Performance
| Financial Metric | 2022 Value |
|---|---|
| Total Revenue | $847.1 million |
| Net Income | $130.4 million |
| Gross Margin | 44.3% |
Strategic Business Segments
| Segment | 2022 Revenue | Key Focus |
|---|---|---|
| Human Nutrition and Health | $344.2 million | Nutritional ingredients and solutions |
| Animal Nutrition and Health | $362.5 million | Specialty feed ingredients |
| Specialty Products | $140.4 million | Specialty chemical technologies |
Global Market Presence
Balchem Corporation operates in multiple countries, with international sales representing 25.6% of total revenue in 2022.
Research and Development
R&D investment for 2022 was $38.6 million, representing 4.6% of total revenue.
Key Performance Indicators
- Employee Count: 1,250 (as of December 31, 2022)
- Global Manufacturing Facilities: 14
- Research Centers: 3
How Balchem Corporation (BCPC) Works
Company Overview
Balchem Corporation is a global specialty and fine chemicals company headquartered in New Hampton, New York. As of 2024, the company operates across four primary business segments.
| Business Segment | Primary Focus | 2023 Revenue |
|---|---|---|
| Human Nutrition & Health | Nutritional ingredients and solutions | $487.2 million |
| Animal Nutrition & Health | Nutritional solutions for livestock | $336.5 million |
| Specialty Products | Industrial and medical applications | $243.8 million |
| Industrial Products | Specialty chemicals and materials | $195.6 million |
Financial Performance
Balchem Corporation reported the following key financial metrics for 2023:
- Total Revenue: $1.263 billion
- Net Income: $153.4 million
- Gross Margin: 44.2%
- Operating Cash Flow: $218.6 million
Global Presence
The company maintains operations in multiple countries, with manufacturing facilities in:
- United States
- Norway
- France
- China
- Brazil
Research and Development
In 2023, Balchem invested $62.3 million in research and development, representing 4.9% of total revenue.
Stock Performance
| Stock Symbol | Price (January 2024) | Market Capitalization |
|---|---|---|
| BCPC | $71.45 | $2.34 billion |
Employee Base
As of December 31, 2023, Balchem Corporation employed 1,642 individuals worldwide.
How Balchem Corporation (BCPC) Makes Money
Business Segments
Balchem Corporation generates revenue through four primary business segments:
| Segment | 2022 Revenue | Primary Products/Services |
|---|---|---|
| Human Nutrition & Health | $693.9 million | Microencapsulated ingredients, choline, nutritional solutions |
| Animal Nutrition & Health | $330.1 million | Specialty nutrition products for livestock, companion animals |
| Specialty Products | $236.2 million | Industrial and medical applications, medical imaging |
| Industrial Products | $176.1 million | Chelated minerals, food preservation, industrial chemicals |
Revenue Breakdown
Total company revenue for 2022: $1.436 billion
Key Revenue Drivers
- Human Nutrition & Health segment represents 48.3% of total revenue
- Animal Nutrition & Health contributes 23% of total revenue
- Specialty Products account for 16.5% of total revenue
- Industrial Products generate 12.3% of total revenue
Market Presence
Global operations in multiple countries with manufacturing facilities in United States, Netherlands, and Germany.
| Geographic Revenue | Percentage |
|---|---|
| United States | 81% |
| International Markets | 19% |
Financial Performance
2022 financial metrics:
- Gross Profit Margin: 44.3%
- Net Income: $193.4 million
- Operating Cash Flow: $254.6 million
Balchem Corporation (BCPC) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.